Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 1.40% this year. Over the last six months, there has been a stronger performance of -14.66%. The price of AZN leaped by -4.38% during the last 30 days period. For the last 5-days stocks have improved 2.85%.
Astrazeneca plc ADR’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $87.68 on 08/30/24 and a low of $60.47 for the same time frame on 02/12/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of AZN Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Astrazeneca plc ADR’s current trading price is -22.11% away from its 52-week high, while its distance from the 52-week low is 12.93%. The stock’s price range during this time has been between $60.47 and $87.68. The trading volume for the Healthcare sector company’s shares reached about 2.33 million for the day, which was lower than the average daily volume of 5.45 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Astrazeneca plc ADR (AZN) has experienced a quarterly decline of -20.36% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 211.74B and boasts a workforce of 89900 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 76.84, with a change in price of -10.92. Similarly, Astrazeneca plc ADR recorded 5,142,858 in trading volume during the last 100 days, posting a change of -13.78%.
AZN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for AZN stands at 0.78. Similarly, the long-term debt-to-equity ratio is also 0.74.
AZN Stock Stochastic Average
Today’s raw stochastic average for Astrazeneca plc ADR over the last 50 days is 32.75%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 94.42%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 59.41% and 47.64%, respectively.
